Home / Organizations / Novo Nordisk

Novo Nordisk

Novo Nordisk is a global healthcare company with more than 90 years of inventions and hard work in diabetes care. They have also developed products that enable people defeat other serious chronic conditions: haemophilia, growth disorders and obesity. Headquartered in Denmark, Novo Nordisk employs approximately 39,700 people in 75 countries. Approximately 42% of employees are located in Denmark (16,669) and 58% in the rest of the world (North America: 6,365, Japan & Korea: 1,127, China: 4,560, International Operations: 6,958, Europe: 4,443). It markets its products in more than 180 countries. It is the largest publicly traded company in the Nordic countries by market capitalization.

The company was ranked 25th among 100 best companies to work for in 2010 by Fortune. In January 2012, Novo Nordisk was named as the most sustainable company in the world by the business magazine Corporate Knights. Novo Nordisk was ranked 72nd on “Fortune’s 100 Best Companies to Work For®” list within the U.S. state of New Jersey as of January 2014.

Product Portfolio:

  • Tresiba
  • Liraglutide 3 Mg
  • Ryzodeg
  • NovoPen Echo

Company Information

Type Publicly traded Aktieselskab
Traded as OMX: NOVO B
NYSE: NVO
Industry Pharmaceuticals, health care
Founded 1923
Founder August and Marie Krogh
Headquarters Bagsværd, Denmark
Key people Lars Rebien Sørensen (Management President and CEO)
Jesper Brandgaard (Management CFO)
Göran Ando (Board Chairman)
Jeppe Christiansen (Board Vice Chairman)
Henrik Gürtler (Board President and CEO)
Products Ryzodeg, Victoza, NovoEight, Activella, Novolin, Levemir, NovoSeven, Norditropin, Tresiba
Revenue DKK 83.57 billion (2013)
Net income DKK 31.49 billion (2013)
Number of employees Approximately 39,700 employees (June 2015)
Subsidiaries NA
Website www.novonordisk.com

Check Also

Teva Pharmaceutical Industries Ltd.

The company known today as Teva Pharmaceutical Industries Ltd. was established in Jerusalem in 1901. It …